Urgent.News

What's breaking now, across thousands of outlets.

Science

STAT+: Amgen’s Repatha linked to fewer heart attacks

Pithy intro text about the biopharma milieu. Novartis cites more tumor reports after Zolgensma Novartis has disclosed seven previously unreported cases of tumors in children who received Zolgensma, its gene therapy…

STAT+: Amgen’s Repatha linked to fewer heart attacks

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Read the original at statnews.com →

More in Science

More from Friday 6 November →